Health Care & Life Sciences » Pharmaceuticals | Kainos Laboratories Inc.

Kainos Laboratories Inc. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
Sales/Revenue
5,803
5,476
5,346
4,703
4,387
Cost of Goods Sold (COGS) incl. D&A
3,940
3,487
3,281
2,583
2,409
Gross Income
1,863
1,989
2,065
2,121
1,977
SG&A Expense
1,535
1,578
1,613
1,637
1,512
EBIT
318
401
442
475
456
Unusual Expense
-
-
-
-
74
Non Operating Income/Expense
11
11
7
6
6
Interest Expense
18
15
13
11
9
Pretax Income
313
378
437
458
379
Income Tax
120
148
141
148
101
Consolidated Net Income
193
230
296
310
278
Net Income
193
230
296
310
278
Net Income After Extraordinaries
193
230
296
310
278
Net Income Available to Common
193
230
296
310
278
EPS (Basic)
43.37
51.73
69.39
74.12
66.49
Basic Shares Outstanding
4
4
4
4
4
EPS (Diluted)
43.37
51.73
69.39
74.12
66.49
Diluted Shares Outstanding
4
4
4
4
4
EBITDA
452
538
586
607
567
Other Operating Expense
10
10
9
9
9
Non-Operating Interest Income
-
-
2
2
1

About Kainos Laboratories

View Profile
Address
2-38-18 Hongo
Tokyo Tokyo 113
Japan
Employees -
Website http://www.kainos.co.jp
Updated 09/14/2018
Kainos Laboratories, Inc. engages in the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products. It is also involved in the development, manufacture, marketing, distribution, import and export of physical and chemical measurement instruments, medical supplies, nutrition supplements, foodstuff, animal feed and related products. The company was founded on May 1, 1975 and is headquartered in Tokyo, Japan.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.